Proteomic portrait of human breast cancer progression identifies novel prognostic markers.

Breast cancer is the second leading cause of cancer death for women in the United States. Of the different subtypes, estrogen receptor-negative (ER(-)) tumors, which are ErbB2+ or triple-negative, carry a relatively poor prognosis. In this study, we used system-wide analysis of breast cancer proteomes to identify proteins that are associated with the progression of ER(-) tumors. Our two-step approach included an initial deep analysis of cultured cells that were obtained from tumors of defined breast cancer stages, followed by a validation set using human breast tumors. Using high-resolution mass spectrometry and quantification by Stable Isotope Labeling with Amino Acids in Cell Culture (SILAC), we identified 8,750 proteins and quantified 7,800 of them. A stage-specific signature was extracted and validated by mass spectrometry and immunohistochemistry on tissue microarrays. Overall, the proteomics signature reflected both a global loss of tissue architecture and a number of metabolic changes in the transformed cells. Proteomic analysis also identified high levels of IDH2 and CRABP2 and low levels of SEC14L2 to be prognostic markers for overall breast cancer survival. Together, our findings suggest that global proteomic analysis provides information about the protein changes specific to ER(-) breast tumor progression as well as important prognostic information.

[1]  D. Lodygin,et al.  Epigenetic silencing of 14-3-3sigma in cancer. , 2006, Seminars in Cancer Biology.

[2]  Adam Byron,et al.  Integrin ligands at a glance , 2006, Journal of Cell Science.

[3]  Matthias Mann,et al.  Use of stable isotope labeling by amino acids in cell culture as a spike-in standard in quantitative proteomics , 2011, Nature Protocols.

[4]  T. Porter.  Supernatant protein factor and tocopherol-associated protein: an unexpected link between cholesterol synthesis and vitamin E (review). , 2003, The Journal of nutritional biochemistry.

[5]  M. Olivé,et al.  Long-term human breast carcinoma cell lines of metastatic origin: Preliminary characterization , 1978, In Vitro.

[6]  A. Makarov,et al.  Performance evaluation of a hybrid linear ion trap/orbitrap mass spectrometer. , 2006, Analytical chemistry.

[7]  S. Dudoit,et al.  Normalization for cDNA microarray data: a robust composite method addressing single and multiple slide systematic variation. , 2002, Nucleic acids research.

[8]  A. Camargo,et al.  Epigenetic silencing of CRABP2 and MX1 in head and neck tumors. , 2009, Neoplasia.

[9]  T. Schug,et al.  Opposing Effects of Retinoic Acid on Cell Growth Result from Alternate Activation of Two Different Nuclear Receptors , 2007, Cell.

[10]  R. Tibshirani,et al.  Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[11]  Rafael A Irizarry,et al.  Exploration, normalization, and summaries of high density oligonucleotide array probe level data. , 2003, Biostatistics.

[12]  T. Tatusova,et al.  Entrez Gene: gene-centered information at NCBI , 2010, Nucleic Acids Res..

[13]  Xin Gao,et al.  Reduced expression of alpha-tocopherol-associated protein is associated with tumor cell proliferation and the increased risk of prostate cancer recurrence. , 2007, Asian journal of andrology.

[14]  W. Woodward,et al.  The number of positive nodes and the ratio of positive to excised nodes are significant predictors of survival in women with micrometastatic node-positive breast cancer. , 2008, European journal of cancer.

[15]  S. Barsky,et al.  Myoepithelial Cells: Autocrine and Paracrine Suppressors of Breast Cancer Progression , 2005, Journal of Mammary Gland Biology and Neoplasia.

[16]  Matthias Mann,et al.  Proteomic Changes Resulting from Gene Copy Number Variations in Cancer Cells , 2010, PLoS genetics.

[17]  M. Mann,et al.  Super-SILAC mix for quantitative proteomics of human tumor tissue , 2010, Nature Methods.

[18]  R. Tibshirani,et al.  Significance analysis of microarrays applied to the ionizing radiation response , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[19]  O. Petersen,et al.  A new diploid nontumorigenic human breast epithelial cell line isolated and propagated in chemically defined medium , 1987, In Vitro Cellular & Developmental Biology.

[20]  G. Reifenberger,et al.  Aberrant expression of retinoic acid signaling molecules influences patient survival in astrocytic gliomas. , 2011, The American journal of pathology.

[21]  K. Kinzler,et al.  14-3-3σ Is a p53-Regulated Inhibitor of G2/M Progression , 1997 .

[22]  M. Mann,et al.  MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification , 2008, Nature Biotechnology.

[23]  R. Beroukhim,et al.  Molecular definition of breast tumor heterogeneity. , 2007, Cancer cell.

[24]  References , 1971 .

[25]  M. Mann,et al.  Stable Isotope Labeling by Amino Acids in Cell Culture, SILAC, as a Simple and Accurate Approach to Expression Proteomics* , 2002, Molecular & Cellular Proteomics.

[26]  F. Bertucci,et al.  Gene expression profiling of breast cell lines identifies potential new basal markers , 2006, Oncogene.

[27]  G. Vlastos,et al.  Ratios of involved nodes in early breast cancer , 2004, Breast Cancer Research.

[28]  Bin Wang,et al.  Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of α-ketoglutarate-dependent dioxygenases. , 2011, Cancer cell.

[29]  M. Westerfield,et al.  Characterization of paired tumor and non‐tumor cell lines established from patients with breast cancer , 1998, International journal of cancer.

[30]  Kornelia Polyak,et al.  Do Myoepithelial Cells Hold the Key for Breast Tumor Progression? , 2005, Journal of Mammary Gland Biology and Neoplasia.

[31]  Daniel Birnbaum,et al.  Poly(ADP-ribose) polymerase-1 mRNA expression in human breast cancer: a meta-analysis , 2011, Breast Cancer Research and Treatment.

[32]  Ken Chen,et al.  Recurring mutations found by sequencing an acute myeloid leukemia genome. , 2009, The New England journal of medicine.

[33]  M. Mann,et al.  Precision proteomics: The case for high resolution and high mass accuracy , 2008, Proceedings of the National Academy of Sciences.

[34]  M. Hung,et al.  Her2/neu induces all-transretinoic acid (ATRA) resistance in breast cancer cells , 2002, Oncogene.

[35]  Matthias Mann,et al.  Combination of FASP and StageTip-based fractionation allows in-depth analysis of the hippocampal membrane proteome. , 2009, Journal of proteome research.

[36]  John D. Minna,et al.  Molecular Profiling of Breast Cancer Cell Lines Defines Relevant Tumor Models and Provides a Resource for Cancer Gene Discovery , 2009, PloS one.

[37]  M. Mottolese,et al.  Changes in expression of alpha 6/beta 4 integrin heterodimer in primary and metastatic breast cancer. , 1992, British Journal of Cancer.

[38]  R. McLendon,et al.  IDH1 and IDH2 mutations in gliomas. , 2009, The New England journal of medicine.

[39]  R. Tibshirani,et al.  Repeated observation of breast tumor subtypes in independent gene expression data sets , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[40]  A. Berner,et al.  Altered Expression of Metastasis-Associated and Regulatory Molecules in Effusions from Breast Cancer Patients , 2004, Clinical Cancer Research.

[41]  Alexandra Paillusson,et al.  A GFP-based reporter system to monitor nonsense-mediated mRNA decay , 2005, Nucleic acids research.

[42]  J. Thiery,et al.  The importance of being a myoepithelial cell , 2002, Breast Cancer Research.

[43]  J. Russo,et al.  Ultrastructural and immunocytochemical characterization of an immortalized human breast epithelial cell line, MCF-10. , 1990, Cancer research.

[44]  Mina J Bissell,et al.  Myoepithelial cells: good fences make good neighbors , 2005, Breast Cancer Research.

[45]  Christian A. Rees,et al.  Molecular portraits of human breast tumours , 2000, Nature.

[46]  M. Mann,et al.  Universal sample preparation method for proteome analysis , 2009, Nature Methods.

[47]  S. Hanash,et al.  The grand challenge to decipher the cancer proteome , 2010, Nature Reviews Cancer.

[48]  S. Yeh,et al.  Dual expression of α-tocopherol-associated protein and estrogen receptor in normal/benign human breast luminal cells and the downregulation of α-tocopherol-associated protein in estrogen-receptor-positive breast carcinomas , 2009, Modern Pathology.

[49]  M. Mann,et al.  Peptide separation with immobilized pI strips is an attractive alternative to in‐gel protein digestion for proteome analysis , 2008, Proteomics.

[50]  K. Schulz,et al.  Androgen sensitivity of the new human breast cancer cell line MFM-223. , 1991, Cancer research.

[51]  Wen-Lin Kuo,et al.  A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. , 2006, Cancer cell.

[52]  Jun Yao,et al.  Regulation of in situ to invasive breast carcinoma transition. , 2008, Cancer cell.

[53]  J. Minna,et al.  Comparison of features of human breast cancer cell lines and their corresponding tumors. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[54]  W. Godolphin,et al.  Model for breast cancer survival: relative prognostic roles of axillary nodal status, TNM stage, estrogen receptor concentration, and tumor necrosis. , 1988, Cancer research.

[55]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[56]  M. Mann,et al.  Andromeda: a peptide search engine integrated into the MaxQuant environment. , 2011, Journal of proteome research.